We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Analysis & Separations

Stay up to date on the topics that matter to you

INmune Bio

INmune Bio is a clinical stage biotechnology company developing new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer and Alzheimer’s disease.

Latest INmune Bio Content

Article

The Evolving Approach of Targeting Neuroinflammation in Alzheimer's Disease

In this article, we discuss the role of chronic inflammation in Alzheimer's disease and explore the increasing interest in treatments that target neuroinflammation.

Never miss a story

with the Breaking Science News daily newsletter